102 related articles for article (PubMed ID: 1847756)
1. Toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in vitro: H4IIEC3-derived 5L hepatoma cells as a model system.
Wiebel FJ; Klose U; Kiefer F
Toxicol Lett; 1991 Feb; 55(2):161-9. PubMed ID: 1847756
[TBL] [Abstract][Full Text] [Related]
2. 2,3,7,8-Tetrachlorodibenzo-p-dioxin causes unbalanced growth in 5L rat hepatoma cells.
Göttlicher M; Wiebel FJ
Toxicol Appl Pharmacol; 1991 Dec; 111(3):496-503. PubMed ID: 1684072
[TBL] [Abstract][Full Text] [Related]
3. TCDD induces the expression of insulin-like growth factor binding protein 4 in 5L rat hepatoma cells: a cautionary tale of the use of this cell line in studies on dioxin toxicity.
Brandner S; Eberhagen C; Lichtmannegger J; Hieber L; Andrae U
Toxicology; 2013 Jul; 309():107-16. PubMed ID: 23639626
[TBL] [Abstract][Full Text] [Related]
4. Analysis of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced proteome changes in 5L rat hepatoma cells reveals novel targets of dioxin action including the mitochondrial apoptosis regulator VDAC2.
Sarioglu H; Brandner S; Haberger M; Jacobsen C; Lichtmannegger J; Wormke M; Andrae U
Mol Cell Proteomics; 2008 Feb; 7(2):394-410. PubMed ID: 17998243
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of growth by 2,3,7,8-tetrachlorodibenzo-p-dioxin in 5L rat hepatoma cells is associated with the presence of Ah receptor.
Göttlicher M; Cikryt P; Wiebel FJ
Carcinogenesis; 1990 Dec; 11(12):2205-10. PubMed ID: 2176138
[TBL] [Abstract][Full Text] [Related]
6. Ah receptor mediating induction of cytochrome P450IA1 in a novel continuous human liver cell line (Mz-Hep-1). Detection by binding with [3H]2,3,7,8-tetrachlorodibenzo-p-dioxin and relationship to the activity of aryl hydrocarbon hydroxylase.
Roberts EA; Johnson KC; Dippold WG
Biochem Pharmacol; 1991 Jul; 42(3):521-8. PubMed ID: 1650214
[TBL] [Abstract][Full Text] [Related]
7. Quantitative analysis of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced proteome alterations in 5L rat hepatoma cells using isotope-coded protein labels.
Sarioglu H; Brandner S; Jacobsen C; Meindl T; Schmidt A; Kellermann J; Lottspeich F; Andrae U
Proteomics; 2006 Apr; 6(8):2407-21. PubMed ID: 16548065
[TBL] [Abstract][Full Text] [Related]
8. NTP technical report on the toxicology and carcinogenesis studies of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (CAS No. 1746-01-6) in female Harlan Sprague-Dawley rats (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Apr; (521):4-232. PubMed ID: 16835633
[TBL] [Abstract][Full Text] [Related]
9. Cell-type specificity of ectonucleotidase expression and upregulation by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Wood E; Broekman MJ; Kirley TL; Diani-Moore S; Tickner M; Drosopoulos JH; Islam N; Park JI; Marcus AJ; Rifkind AB
Arch Biochem Biophys; 2002 Nov; 407(1):49-62. PubMed ID: 12392715
[TBL] [Abstract][Full Text] [Related]
10. TCDD-inducible plasminogen activator inhibitor type 2 (PAI-2) in human hepatocytes, HepG2 and monocytic U937 cells.
Gohl G; Lehmköster T; Münzel PA; Schrenk D; Viebahn R; Bock KW
Carcinogenesis; 1996 Mar; 17(3):443-9. PubMed ID: 8631129
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of high-density growth arrest in human squamous carcinoma cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).
Hébert CD; Cao QL; Birnbaum LS
Carcinogenesis; 1990 Aug; 11(8):1335-42. PubMed ID: 2387019
[TBL] [Abstract][Full Text] [Related]
12. Bioassay for determining 2,3,7,8-tetrachlorodibenzo-p-dioxin equivalents (TEs) in human hepatoma Hepg2 cells.
Wiebel FJ; Wegenke M; Kiefer F
Toxicol Lett; 1996 Nov; 88(1-3):335-8. PubMed ID: 8920757
[TBL] [Abstract][Full Text] [Related]
13. Quantitative relationship of dioxin-responsive gene expression to dioxin response element in Hep3B and HepG2 human hepatocarcinoma cell lines.
Kim WK; In YJ; Kim JH; Cho HJ; Kim JH; Kang S; Lee CY; Lee SC
Toxicol Lett; 2006 Aug; 165(2):174-81. PubMed ID: 16697128
[TBL] [Abstract][Full Text] [Related]
14. Uroporphyrin accumulation associated with cytochrome P4501A induction in fish hepatoma cells exposed to aryl hydrocarbon receptor agonists, including 2,3,7,8-tetrachlorodibenzo-p-dioxin and planar chlorobiphenyls.
Hahn ME; Chandran K
Arch Biochem Biophys; 1996 May; 329(2):163-74. PubMed ID: 8638948
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of intercellular communication by 2,3,7,8-tetrachlorodibenzo-p-dioxin and dioxin-like PCBs in mouse hepatoma cells (Hepa1c1c7): involvement of the Ah receptor.
De Haan LH; Simons JW; Bos AT; Aarts JM; Denison MS; Brouwer A
Toxicol Appl Pharmacol; 1994 Dec; 129(2):283-93. PubMed ID: 7992318
[TBL] [Abstract][Full Text] [Related]
16. Suppression of cell cycle progression by flavonoids: dependence on the aryl hydrocarbon receptor.
Reiners JJ; Clift R; Mathieu P
Carcinogenesis; 1999 Aug; 20(8):1561-6. PubMed ID: 10426807
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of action of aryl hydrocarbon receptor antagonists: inhibition of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced CYP1A1 gene expression.
Merchant M; Morrison V; Santostefano M; Safe S
Arch Biochem Biophys; 1992 Nov; 298(2):389-94. PubMed ID: 1329656
[TBL] [Abstract][Full Text] [Related]
18. Mouse Hepa 1c1c7 hepatoma cells produce complement component C3; 2,3,7,8-tetrachlorodibenzo-p-dioxin fails to modulate this capacity.
Lin WQ; White KL
J Toxicol Environ Health; 1993 May; 39(1):27-41. PubMed ID: 8492328
[TBL] [Abstract][Full Text] [Related]
19. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induces plasminogen activator inhibitor-1 through an aryl hydrocarbon receptor-mediated pathway in mouse hepatoma cell lines.
Son DS; Rozman KK
Arch Toxicol; 2002 Jul; 76(7):404-13. PubMed ID: 12111005
[TBL] [Abstract][Full Text] [Related]
20. Role of transforming growth factor beta in the proliferative effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on human squamous carcinoma cells.
Hébert CD; Cao QL; Birnbaum LS
Cancer Res; 1990 Nov; 50(22):7190-7. PubMed ID: 2171758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
